Skip to main content
. 2020 May 12;2020(5):CD013238. doi: 10.1002/14651858.CD013238.pub2

Comparison 3. Progression‐free survival.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
3.1 First‐line 2   Hazard Ratio (IV, Random, 95% CI) 0.94 [0.81, 1.10]
3.2 Recurrent disease 3   Hazard Ratio (IV, Random, 95% CI) 0.75 [0.58, 0.96]
3.3 Sensitivity analysis low risk of bias PFS 5   Hazard Ratio (IV, Random, 95% CI) 0.88 [0.77, 1.01]